The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation [PDF]
The cellular protein p32 was isolated originally as a protein tightly associated with the essential splicing factor ASF/SF2 during its purification from HeLa cells. ASF/SF2 is a member of the SR family of splicing factors, which stimulate constitutive splicing and regulate alternative RNA splicing in a positive or negative fashion, depending on where ...
S K, Petersen-Mahrt +5 more
openaire +2 more sources
Interaction of the yeast splicing factor PRP8 with substrate RNA during both steps of splicing [PDF]
PRP8 protein of Saccharomyces cerevisiae interacts directly with pre-mRNA in spliceosomes, shown previously by UV-crosslinking. To analyse at which steps of splicing and with which precursor-derived RNA species the interaction(s) take place, UV-crosslinking was combined with PRP8-specific immunoprecipitation and the coprecipitated RNA species were ...
S, Teigelkamp, E, Whittaker, J D, Beggs
openaire +2 more sources
Although inhibition of the androgen–androgen receptor (AR) axis effectively represses the growth of prostate cancer, most of all cases eventually become castration-resistant prostate cancers (CRPCs).
Ken-ichi Takayama
doaj +1 more source
The Localization of Sites Containing Nascent RNA and Splicing Factors
Sites of transcription in the HeLa nucleus are not diffusely spread throughout euchromatin but are concentrated in approximately 2000 discrete sites or "transcription factories." These sites can be immunolabeled after allowing permeabilized cells to elongate nascent RNA chains in the presence of BrUTP.
Pombo, A, Cook, P
openaire +2 more sources
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes [PDF]
Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; however, the dysregulated splicing ...
A, Sveen +4 more
openaire +2 more sources
RBM17 Interacts with U2SURP and CHERP to Regulate Expression and Splicing of RNA-Processing Proteins
Summary: RNA splicing entails the coordinated interaction of more than 150 proteins in the spliceosome, one of the most complex of the cell’s molecular machines.
Antonia De Maio +9 more
doaj +1 more source
Exploring RNA modifications, editing, and splicing changes in hyperuricemia and gout
Hyperuricemia and gout are two of the most common metabolic disorders worldwide; their incidence is increasing with changes in lifestyle, and they are correlated with many diseases, including renal and cardiovascular diseases.
Chung-Ming Huang +21 more
doaj +1 more source
RNA-splicing factor SART3 regulates translesion DNA synthesis [PDF]
Translesion DNA synthesis (TLS) is one mode of DNA damage tolerance that uses specialized DNA polymerases to replicate damaged DNA. DNA polymerase η (Polη) is well known to facilitate TLS across ultraviolet (UV) irradiation and mutations in POLH are implicated in skin carcinogenesis.
Min Huang +14 more
openaire +2 more sources
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides [PDF]
AbstractAlternative splicing, a fundamental step in gene expression, is deregulated in many diseases. Splicing factors (SFs), which regulate this process, are up- or down regulated or mutated in several diseases including cancer. To date, there are no inhibitors that directly inhibit the activity of SFs.
Polina Denichenko +14 more
openaire +4 more sources
The Caenorhabditis elegans gene mfap-1 encodes a nuclear protein that affects alternative splicing. [PDF]
RNA splicing is a major regulatory mechanism for controlling eukaryotic gene expression. By generating various splice isoforms from a single pre-mRNA, alternative splicing plays a key role in promoting the evolving complexity of metazoans.
Long Ma +5 more
doaj +1 more source

